BIO.B

Bio-Rad Laboratories, Inc. Class B · NYSE

Sector Health Technology
Industry Medical Specialties
Website -
Employees(FY) -
ISIN US0905721082

Performance

-1.31%

-17.53%

-23.72%

-20.49%

-22.04%

YTD

-22.86%

Profile

Advanced Technical Analysis

Technical Analysis of BIO.B 2025-03-13

The stock indicators suggest a bearish sentiment overall, with a Moving Average Score of 0 indicating strong downward pressure, while the Oscillators Score of 45 reflects a neutral stance, and the Technical Score of 22 reinforces the bearish outlook. Collectively, these scores imply a lack of bullish momentum and potential challenges for upward ...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of BIO.B

Stock Rank

Recent News & Updates

2025-02-17 09:45
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio(Zacks)
2025-02-15 10:05
Bio-Rad price target lowered to $447 from $477 at RBC Capital(TipRanks)
2025-02-15 08:03
Bio-Rad Laboratories Full Year 2024 Earnings: EPS Misses Expectations(Simply Wall St.)
2025-02-14 17:14
Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover(Morningstar Research)
2025-02-14 13:57
BIO Q4 Earnings and Revenues Miss Estimates, Stock Down Aftermarket(Zacks)
2025-02-14 12:10
Bio-Rad set to acquire Stilla Technologies(Medical Device Network)
2025-02-14 12:07
Analyst Report: Bio-Rad Laboratories, Inc.(Morningstar Research)
2025-02-14 08:46
UBS Adjusts Price Target on Bio-Rad Laboratories to $355 From $390, Keeps Buy Rating(MT Newswires)
2025-02-14 07:42
RBC Cuts Price Target on Bio-Rad Laboratories to $447 From $477, Keeps Outperform Rating(MT Newswires)
2025-02-14 07:10
Q4 2024 Bio Rad Laboratories Inc Earnings Call(Thomson Reuters StreetEvents)
2025-02-14 05:42
Bruker Q4 Earnings & Revenues Surpass Estimates, Stock Falls(Zacks)
2025-02-14 02:22
Bio-Rad Laboratories Inc (BIO) Q4 2024 Earnings Call Highlights: Navigating Challenges with ...(GuruFocus.com)
2025-02-13 17:45
Bio-Rad Laboratories (BIO) Misses Q4 Earnings and Revenue Estimates(Zacks)
2025-02-13 16:58
Bio-Rad: Q4 Earnings Snapshot(Associated Press Finance)
2025-02-13 16:38
Bio-Rad Laboratories' Q4 Adjusted Earnings, Revenue Fall(MT Newswires)
2025-02-13 16:20
Bio-Rad Reports Fourth-Quarter and Full-Year 2024 Financial Results(Business Wire)
2025-02-13 16:15
Bio-Rad Offers to Acquire Digital PCR Developer Stilla Technologies(Business Wire)
2025-02-12 08:37
CVS Health Stock Up on Q4 Earnings & Revenue Beat, Margins Rise(Zacks)
2025-02-12 07:20
Bio-Rad Laboratories Inc (BIO) Q4 2024 Earnings Report Preview: What To Look For(GuruFocus.com)
2025-02-11 08:46
OncoCyte prices $29.1M equity offering(TipRanks)
2025-02-10 08:30
Oncocyte Prices $29.1 Million Equity Offering(GlobeNewswire)
2025-02-10 07:30
Omnicell Q4 Earnings & Revenues Beat, Stock Up, Gross Margin Rises(Zacks)
2025-02-07 06:50
QIAGEN Q4 Earnings Miss, Stock Crashes, Margins Expand(Zacks)
2025-02-07 06:47
PAHC Stock Falls Despite Q2 Earnings & Revenue Beat, Margins Increase(Zacks)
2025-02-06 10:00
Earnings Preview: Bio-Rad Laboratories (BIO) Q4 Earnings Expected to Decline(Zacks)
2025-02-06 07:21
Hologic Q1 Earnings Beat, Stock Falls on Dismal '25 Sales Guidance(Zacks)
2025-02-04 19:00
BIO: Lowering target price to $279.00(Argus Research)
2025-02-04 09:40
Has BioRad Laboratories (BIO) Outpaced Other Medical Stocks This Year?(Zacks)
2025-02-04 06:52
RBC Trims Price Target on Bio-Rad Laboratories to $477 From $481, Keeps Outperform Rating(MT Newswires)
2025-01-28 19:00
BIO: Raising target price to $294.00(Argus Research)

Page 1 of 3

previousnext

Disclaimer: The information provided here and on kavout.com is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout makes no recommendations regarding investment decisions based on this information. You are solely responsible for your investments. Please conduct your own research and consult qualified financial advisors before investing. Past performance does not guarantee future results.